Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Molina Healthcare Inc (NYSE: MOH) was $143.52 for the day, up 1.86% from the previous closing price of $140.9. In other words, the price has increased by $1.86 from its previous closing price. On the day, 1.58 million shares were traded. MOH stock price reached its highest trading level at $145.0 during the session, while it also had its lowest trading level at $140.02.
Ratios:
Our analysis of MOH’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.92.
On October 16, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $203.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $207.Goldman initiated its Neutral rating on October 14, 2025, with a $207 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 06 ’25 when ROMNEY RONNA sold 700 shares for $153.74 per share. The transaction valued at 107,618 led to the insider holds 17,131 shares of the business.
WOYS JAMES bought 10,000 shares of MOH for $1,559,365 on Aug 04 ’25. The Chief Operating Officer now owns 74,331 shares after completing the transaction at $155.94 per share. On Aug 04 ’25, another insider, ROMNEY RONNA, who serves as the Director of the company, bought 700 shares for $157.99 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 7376928256 and an Enterprise Value of 2781927936. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.90, and their Forward P/E ratio for the next fiscal year is 9.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17 while its Price-to-Book (P/B) ratio in mrq is 1.75. Its current Enterprise Value per Revenue stands at 0.065 whereas that against EBITDA is 1.909.
Stock Price History:
The Beta on a monthly basis for MOH is 0.52, which has changed by -0.54445523 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $359.97, while it has fallen to a 52-week low of $139.29. The 50-Day Moving Average of the stock is -19.56%, while the 200-Day Moving Average is calculated to be -42.51%.
Shares Statistics:
MOH traded an average of 1.48M shares per day over the past three months and 1748760 shares per day over the past ten days. A total of 51.00M shares are outstanding, with a floating share count of 50.83M. Insiders hold about 1.10% of the company’s shares, while institutions hold 107.89% stake in the company. Shares short for MOH as of 1761868800 were 3140447 with a Short Ratio of 2.17, compared to 1759190400 on 3379486. Therefore, it implies a Short% of Shares Outstanding of 3140447 and a Short% of Float of 8.129999999999999.
Earnings Estimates
The dynamic stock of Molina Healthcare Inc (MOH) is currently being evaluated by a team of 16.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $4.58, with high estimates of $6.58 and low estimates of $2.7.
Analysts are recommending an EPS of between $18.92 and $13.26 for the fiscal current year, implying an average EPS of $14.99. EPS for the following year is $14.83, with 17.0 analysts recommending between $21.09 and $11.0.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 12 analysts. It ranges from a high estimate of $11.29B to a low estimate of $10.45B. As of. The current estimate, Molina Healthcare Inc’s year-ago sales were $10.5BFor the next quarter, 12 analysts are estimating revenue of $11.64B. There is a high estimate of $12.19B for the next quarter, whereas the lowest estimate is $11.16B.
A total of 13 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $45.34B, while the lowest revenue estimate was $44.12B, resulting in an average revenue estimate of $44.79B. In the same quarter a year ago, actual revenue was $40.65BBased on 12 analysts’ estimates, the company’s revenue will be $47.13B in the next fiscal year. The high estimate is $48.42B and the low estimate is $44.85B.
